Dapagliflozin versus metolazone in heart failure resistant to loop diuretics.
Sign Up to like & getrecommendations! Published in 2023 at "European heart journal"
DOI: 10.1093/eurheartj/ehad341
Abstract: BACKGROUND AND AIMS To examine the decongestive effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin compared to the thiazide-like diuretic metolazone in patients hospitalized for heart failure and resistant to treatment with intravenous furosemide. METHODS… read more here.
Keywords: heart failure; heart; failure resistant; metolazone ... See more keywords